Brain technology company Darmiyan has received De Novo US Food and Drug Administration (FDA) approval for its first-in-class dementia test BrainSee.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,